Virtual screening study to identify GSK-3β inhibitors: A combined ligand-based and structure-based drug discovery approach. IJBB [Internet]. 2025 Aug. 18 [cited 2026 May 30];62(9):978-89. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/15726